Expression of E-cadherin, Matrix Metalloproteinase, and Vascular Endothelial Growth Factor in Squamous Cell Carcinoma and Adenocarcinoma of the Lung.
- Author:
Ji Sun SONG
;
Mee Yon CHO
;
Kwang Hwa PARK
;
Soon Hee JUNG
;
Kwang Gil LEE
- Publication Type:Original Article
- Keywords:
Non-small cell lung carcinoma;
E-cadherin;
Matrix metalloproteinase;
Vascular endothelial growth factor;
Prognostic factor
- MeSH:
Adenocarcinoma*;
Basement Membrane;
Cadherins*;
Carcinoma, Squamous Cell*;
Coloring Agents;
Endothelial Cells;
Extracellular Matrix;
Humans;
Lung*;
Lymph Nodes;
Neoplasm Metastasis;
Prognosis;
Survival Rate;
Vascular Endothelial Growth Factor A*
- From:Korean Journal of Pathology
2000;34(12):972-981
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
E-cadherin is a calcium-dependent epithelial adhesion molecule which plays a role in the initial step of invasion of cancer cells. The step that follows the migration of separated tumor cells is a proteolytic lysis of basement membrane and extracellular matrix by protease of epithelial and endothelial cells such as matrix metalloproteinase (MMP). Vascular endothelial growth factor (VEGF) is known to be an endothelial cell-specific powerful mitogen as well as a vascular permeability factor. This study is aimed to evaluate the correlation between expression of these factors and pathologic or clinical variables and the roles and prognostic significance of those factors in squmous cell carcinoma and adenocarcinoma of the lung. Immunohistochemical stains were performed for E-cadherin, MMP-2, and VEGF in surgically resected specimens from 90 patients with squmous cell carcinoma and adenocarcinoma of the lung. Mean age of the patients was 59.7 years. Histologic type was categorized into 56 cases of squamous cell carcinoma and 34 cases of adenocarcinoma. Mean survival period of the 35 patients was 54 months. The immunohistochemical stains for E-cadherin, MMP-2, and VEGF revealed positive reaction in 67 cases (74.4%), 43 cases (47.8%), and 34 cases (37.8%), respectively. The expression of E-cadherin was higher in adenocarcinoma (82.4%) than in squamous cell carcinoma (69.6%). MMP-2 was expressed in the tumor cells, especially those invading into the surrounding stroma. The expression of MMP-2 was significantly correlated with the survival rate (p<0.05). The expression of VEGF in the tumor cells was significantly higher in cases with lymph node metastasis (p<0.05). In conclusion, these findings suggest that the expression of MMP-2 and VEGF predict poor prognosis of patients with squmous cell carcinoma and adenocarcinoma of the lung and that VEGF may play a role in tumor metastasis.
